Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
One of the best parts about building a trading community isn’t just sharing my own ideas—it’s seeing others take those ideas and make them even better.
Case in point: Yesterday, I closed out a call calendar spread in $AVGO for a solid win. The...
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
EFA has multiple confluent projections and extensions in the 89-93 area. This should prove to be major resistance for now. Additionally, take note of the blue highlighted 3 drives to a top pattern. The key to this pattern - note the...
